What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Neuroscience
- Gene
Igor Branchi spends much of his time researching Neuroscience, Hippocampus, Developmental psychology, Neuroplasticity and Brain-derived neurotrophic factor.
His research in Neuroscience intersects with topics in Neurotrophic factors, Neurotrophin, Microglia and Nerve growth factor.
A component of his Hippocampus study involves Endocrinology and Internal medicine.
Igor Branchi has researched Developmental psychology in several fields, including Serotonergic and Serotonin.
His studies in Neuroplasticity integrate themes in fields like Behavioural despair test, Open field, Neurotransmission, Hippocampal formation and Corticosterone.
His Brain-derived neurotrophic factor study integrates concerns from other disciplines, such as Elevated plus maze and Thigmotaxis.
His most cited work include:
- Polybrominated diphenyl ethers: neurobehavioral effects following developmental exposure. (280 citations)
- Ultrasonic vocalisation emitted by infant rodents: a tool for assessment of neurobehavioural development. (234 citations)
- Effects of perinatal exposure to a polybrominated diphenyl ether (PBDE 99) on mouse neurobehavioural development. (193 citations)
What are the main themes of his work throughout his whole career to date?
Igor Branchi mainly focuses on Internal medicine, Endocrinology, Neuroscience, Developmental psychology and Fluoxetine.
His Internal medicine study incorporates themes from Antidepressant, Mood disorders, Depression and Oncology.
His primary area of study in Endocrinology is in the field of Hippocampus.
His biological study deals with issues like Brain-derived neurotrophic factor, which deal with fields such as Open field.
His Developmental psychology research incorporates themes from Social relation, Environmental enrichment, Weaning and Nest.
The concepts of his Fluoxetine study are interwoven with issues in Chronic stress, Pharmacology, Anhedonia and Mood.
He most often published in these fields:
- Internal medicine (35.48%)
- Endocrinology (26.61%)
- Neuroscience (24.19%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (35.48%)
- Antidepressant (12.10%)
- Major depressive disorder (6.45%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Antidepressant, Major depressive disorder, Depression and Inflammation.
The study incorporates disciplines such as Endocrinology and Oncology in addition to Internal medicine.
The Antidepressant study which covers Mood that intersects with Pharmacology, Fluoxetine, STAR*D, Clinical trial and Young adult.
His study in the fields of Mood disorders under the domain of Depression overlaps with other disciplines such as Differential diagnosis.
His Inflammation research includes themes of Psychopharmacology, Multivariate analysis and Neuroscience.
His work in Neuroscience tackles topics such as Treatment efficacy which are related to areas like Neuroplasticity.
Between 2018 and 2021, his most popular works were:
- Stress resilience during the coronavirus pandemic. (70 citations)
- Interplay between inflammation and neural plasticity: Both immune activation and suppression impair LTP and BDNF expression (21 citations)
- Combined Fluoxetine and Metformin Treatment Potentiates Antidepressant Efficacy Increasing IGF2 Expression in the Dorsal Hippocampus. (11 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Genetics
His scientific interests lie mostly in Internal medicine, Severe acute respiratory syndrome coronavirus 2, 2019-20 coronavirus outbreak, Mood and Antidepressant.
His Internal medicine study integrates concerns from other disciplines, such as Endocrinology and Oncology.
His biological study spans a wide range of topics, including Young adult and Mood disorders, Depression.
His Mood research is multidisciplinary, relying on both Metformin, Anhedonia, Fluoxetine, Hippocampus and Pharmacology.
His Hippocampus research includes themes of Major depressive disorder and Long-term potentiation.
In general Antidepressant, his work in Citalopram is often linked to Socioeconomic status linking many areas of study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
